RC
QTTB icon

RBF Capital’s Q32 Bio QTTB Stock Holding History

RBF Capital’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,261
Closed -$35.7K – 578
2023
Q4 		$35.7K Hold
3,261
– – ﹤0.01% 540
2023
Q3 		$68.7K Hold
3,261
– – ﹤0.01% 518
2023
Q2 		$52K Hold
3,261
– – ﹤0.01% 515
2023
Q1 		$60.5K Sell
3,261
-901
-22% -$22.4K ﹤0.01% 495
2022
Q4 		$94K Buy
4,162
+829
+25% +$22K 0.01% 502
2022
Q3 		$97K Hold
3,333
– – 0.01% 497
2022
Q2 		$118K Buy
+3,333
New +$114K 0.01% 489

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RBF Capital's QTTB Position: Q1 2024 in Review

RBF Capital sold out of Q32 Bio (QTTB) in Q1 2024, closing a stake of 3,261 shares — an estimated $35.7K sold.

RBF Capital first reported a position in QTTB in Q2 2022 and held it in 7 quarters. The position peaked at $118K in Q2 2022. 39 funds tracked by Wall St. Rank hold QTTB as of Q1 2024.

  • RBF Capital reported no remaining Q32 Bio position as of Q1 2024 after selling out during the quarter.
  • RBF Capital sold 3,261 Q32 Bio shares in Q1 2024, an estimated $35.7K.
  • RBF Capital first reported a position in Q32 Bio in Q2 2022 and held it in 7 quarters.
  • RBF Capital's Q32 Bio position peaked at $118K in Q2 2022.
  • 39 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2024.

Based on RBF Capital's 13F filing for Q1 2024, filed 15 May 2024.